Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient

• Main Authors: Fournier M (Author), Chen C (Author), Kuznik A (Author), Proudfoot C (Author), Mallya UG (Author), Michaud K (Author)
• Format: Book
• Published: Dove Medical Press, 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Marie Fournier,1 Chieh-I Chen,2 Andreas Kuznik,2 Clare Proudfoot,3 Usha G Mallya,4 Kaleb Michaud5,6 1Health Economics & Value Assessment, Sanofi France, Chilly-Mazarin, France; 2Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; 3Sanofi, Guildford, UK; 4Sanofi, Bridgewater, NJ, USA; 5Universit...